Edison Investment Research

Regional REIT (RGL); declares a dividend of 1.85p/sh for 2Q18

RGL will pay a dividend of 1.85 pence per share (pps) for the period 1 April 2018 to 30 June 2018 (1 April 2017 to 30 June 2017: 1.80 pps).

eServGlobal (ESG); 1H results: EBITDA loss narrows to €0.9m ($1.4mm) due to cost control

ESG posted revenue of €3.6m ($5.6m) for the six months ending June 2018. Orders received exceeded forecasts at €7.7m ($12.0m).

Raven Property Group (RAV); RAVC convertible preference share dividend payment on 1 October 2018

Stock down 0.25% to 40.50p at 8:00

RAV has announced that the quarterly payment of the dividend in respect of the convertible redeemable preference shares of no par value (convertible preference shares) with ticker RAVC will be made on 1 October 2018 for the period from 30 June 2018 to (but excluding) 30 September 2018.

SCISYS (SSY); helps to capture and preserve the UK’s radio output

Stock up 2.88% to 178.50p at 08:04

SSY has been awarded a contract by the British Library to deliver a national Digital Radio Archive Management solution that will capture and preserve a representative part of the UK’s radio output.

SCISYS (SSY); trading update: positive first half trading performance

Stock up 2.88% to 178.50p at 08:04

SSY’s cash generation continues to be strong. A positive 1H trading performance is reflected by the reduction in net debt from the 2017 closing position of £5.9m to £3.3m by 30 June 2018.

appScatter Group (APPS);announces issuance of deferred shares in relation to Priori acquisition

Stock flat at 36.50p at 8:05

APPS will issue 357,698 deferred shares to Priori vendors as per the terms of the sale and purchase agreement of the Priori acquisition deal.

IQE (IQE); H1 2018 results: revenue increases by 4.0% to £73.4m

Stock down 3.27% to 100.60p at 08:25

IQE announced its unaudited half-year results for the six months to 30 June 2018. Reported PBT increased by £1.0m to £6.6m (H1 2017: £5.6m). Forex headwind produced a drag of c. £2m on reported PBT.

Oxford Biomedica (OXB); European Commission approves Kymriah

Stock up 0.89% to 859.60p at 8:27

OXB announced the European Commission’s approval for the Novartis CAR-T cell therapy, Kymriah (a ground breaking one-time treatment that uses a patient’s own T cells to fight cancer).

Angle (AGL); Parsortix provides first evidence of circulating tumour cells in glioblastoma

Stock up 5.16% to 48.90p at 8:16

A collaborative research work done in University of Basel has demonstrated that AGL’s Parsortix system with a simple blood test can detect circulating tumour cells (CTCs) in human glioblastoma and this can be analyzed to provide molecular characterization of cancer.

TOWN Centre Securities (TOWN); acquisition of The Cube for £12m from Aviva

TOWN has announced the acquisition of The Cube, Leeds, for £12m from Aviva. The completion of the purchase is set for 1 October 2018.